A novel fluorescent thrombin binding aptamer (TBA), conjugated with the environment-sensitive dansyl probe at the 3'-end and a beta-cyclodextrin residue at the 5'-end, has been efficiently synthesized exploiting Cu(I)-catalyzed azide-alkyne cycloaddition procedures. Its conformation and stability in solution have been studied by an integrated approach, combining in-depth NMR, CD, fluorescence and DSC studies. ITC measurements have allowed to analyze in detail its interaction with human thrombin. All the collected data show that this bis-conjugated aptamer fully retains its G-quadruplex formation ability and thrombin recognition properties, with the terminal appendages only marginally interfering with the conformational behavior of TBA. Fold...
A small library of cyclic TBA analogues (named cycTBA I-IV), obtained by covalently connecting its 5...
Thrombin-binding DNA aptamer (TBA), with a consensus 15-base sequence: d(GGTTGGTGTGGTTGG), can fold ...
First studies on thrombin-inhibiting DNA aptamers were reported in 1992, and since then a large numb...
A novel fluorescent thrombin binding aptamer (TBA), conjugated with the environment-sensitive dansyl...
A novel fluorescent thrombin binding aptamer (TBA), conjugated with the environmentally sensitive da...
The thrombin binding aptamer (TBA) is a well characterized chair-like, antiparallel quadruplex struc...
Progress in understanding and treatment of thrombotic diseases requires new effective methods for th...
In the search for optimized thrombin binding aptamers (TBAs), we herein describe the synthesis of a ...
The thrombin binding aptamer (TBA) is a 15-mer oligonucleotide (ON) which folds into a typical chair...
The thrombin-binding aptamer (TBA), which shows anticoagulant properties, is one of the most studied...
Aptamer-based biosensors offer promising perspectives for high performance, specific detection of pr...
The thrombin binding aptamer (TBA) is a promising nucleic acid-based anticoagulant. We studied the e...
International audienceImportant efforts have been devoted toward the development of modified oligonu...
Aptamers are structured oligonucleotides that recognize molecular targets and can function as direct...
An acyclic pyrimidine analogue, containing a five member cycle fused on the pyrimidine ring, was syn...
A small library of cyclic TBA analogues (named cycTBA I-IV), obtained by covalently connecting its 5...
Thrombin-binding DNA aptamer (TBA), with a consensus 15-base sequence: d(GGTTGGTGTGGTTGG), can fold ...
First studies on thrombin-inhibiting DNA aptamers were reported in 1992, and since then a large numb...
A novel fluorescent thrombin binding aptamer (TBA), conjugated with the environment-sensitive dansyl...
A novel fluorescent thrombin binding aptamer (TBA), conjugated with the environmentally sensitive da...
The thrombin binding aptamer (TBA) is a well characterized chair-like, antiparallel quadruplex struc...
Progress in understanding and treatment of thrombotic diseases requires new effective methods for th...
In the search for optimized thrombin binding aptamers (TBAs), we herein describe the synthesis of a ...
The thrombin binding aptamer (TBA) is a 15-mer oligonucleotide (ON) which folds into a typical chair...
The thrombin-binding aptamer (TBA), which shows anticoagulant properties, is one of the most studied...
Aptamer-based biosensors offer promising perspectives for high performance, specific detection of pr...
The thrombin binding aptamer (TBA) is a promising nucleic acid-based anticoagulant. We studied the e...
International audienceImportant efforts have been devoted toward the development of modified oligonu...
Aptamers are structured oligonucleotides that recognize molecular targets and can function as direct...
An acyclic pyrimidine analogue, containing a five member cycle fused on the pyrimidine ring, was syn...
A small library of cyclic TBA analogues (named cycTBA I-IV), obtained by covalently connecting its 5...
Thrombin-binding DNA aptamer (TBA), with a consensus 15-base sequence: d(GGTTGGTGTGGTTGG), can fold ...
First studies on thrombin-inhibiting DNA aptamers were reported in 1992, and since then a large numb...